Nov 2024 Articles

Articles
2024 Guidelines of the Taiwan Society of Cardiology on the Primary Prevention of Atherosclerotic Cardiovascular Disease — Part II
Chao TH, Lin TH, Cheng CI, et al.
First published: November 30, 2024 DOI: 10.6515/ACS.202411_40(6).20240724B
View
- Share
Articles
Traditional Risk Factors, Optimal Cardiovascular Health, and Elevated Lipoprotein(a)
Razavi AC, Reyes MP, Wilkins JT, et al.
Journal:
Eur J Prev Cardiol

First published: November 28, 2024 DOI: 10.1093/eurjpc/zwae382
View
- Share
Articles
Ezetimibe: Integrating Established Use with New Evidence – A Comprehensive Review
Olmastroni E, Scotti S, Galimberti F, et al.
Journal:
Curr Atheroscler Rep

First published: November 25, 2024 DOI: 10.1007/s11883-024-01248-w
View
- Share
Articles
Oral Muvalaplin for Lowering of Lipoprotein(a): A Randomized Clinical Trial
Nicholls SJ, Ni W, Rhodes GM, et al.
Journal:
JAMA

First published: November 18, 2024 DOI: 10.1001/jama.2024.24017
View
- Share
Articles
Intensive Lifestyle Intervention, Cardiac Biomarkers, and Cardiovascular Outcomes in Diabetes: Look AHEAD Cardiac Biomarker Ancillary Study
Patel KV, Chunawala Z, Verma S, et al.
Journal:
J Am Coll Cardiol

First published: November 15, 2024 DOI: 10.1016/j.jacc.2024.11.004
View
- Share
Articles
Lp(a): A Rapidly Evolving Therapeutic Landscape
Anchouche K, Thanassoulis G
Journal:
Curr Atheroscler Rep

First published: November 11, 2024 DOI: 10.1007/s11883-024-01252-0
View
- Share

Nov 2024 Articles

Articles

2024 Guidelines of the Taiwan Society of Cardiology on the Primary Prevention of Atherosclerotic Cardiovascular Disease — Part II

Chao TH, Lin TH, Cheng CI, et al.

Articles

Traditional Risk Factors, Optimal Cardiovascular Health, and Elevated Lipoprotein(a)

Razavi AC, Reyes MP, Wilkins JT, et al.

Articles

Ezetimibe: Integrating Established Use with New Evidence – A Comprehensive Review

Olmastroni E, Scotti S, Galimberti F, et al.

Articles

Oral Muvalaplin for Lowering of Lipoprotein(a): A Randomized Clinical Trial

Nicholls SJ, Ni W, Rhodes GM, et al.

Articles

Intensive Lifestyle Intervention, Cardiac Biomarkers, and Cardiovascular Outcomes in Diabetes: Look AHEAD Cardiac Biomarker Ancillary Study

Patel KV, Chunawala Z, Verma S, et al.

Articles

Lp(a): A Rapidly Evolving Therapeutic Landscape

Anchouche K, Thanassoulis G

Articles

2024 Guidelines of the Taiwan Society of Cardiology on the Primary Prevention of Atherosclerotic Cardiovascular Disease — Part II

Chao TH, Lin TH, Cheng CI, et al.

Share

Articles

Traditional Risk Factors, Optimal Cardiovascular Health, and Elevated Lipoprotein(a)

Razavi AC, Reyes MP, Wilkins JT, et al.

Share

Articles

Ezetimibe: Integrating Established Use with New Evidence – A Comprehensive Review

Olmastroni E, Scotti S, Galimberti F, et al.

Share

Articles

Oral Muvalaplin for Lowering of Lipoprotein(a): A Randomized Clinical Trial

Nicholls SJ, Ni W, Rhodes GM, et al.

Share

Articles

Intensive Lifestyle Intervention, Cardiac Biomarkers, and Cardiovascular Outcomes in Diabetes: Look AHEAD Cardiac Biomarker Ancillary Study

Patel KV, Chunawala Z, Verma S, et al.

Share

Articles

Lp(a): A Rapidly Evolving Therapeutic Landscape

Anchouche K, Thanassoulis G

Share